SEATTLE, Nov. 4 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference in New York City on Tuesday, November 11, 2008 at 11:35 a.m. E.T.
